These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 34712667)
1. DNA Damage Repair Deficiency in Pancreatic Ductal Adenocarcinoma: Preclinical Models and Clinical Perspectives. Stoof J; Harrold E; Mariottino S; Lowery MA; Walsh N Front Cell Dev Biol; 2021; 9():749490. PubMed ID: 34712667 [TBL] [Abstract][Full Text] [Related]
2. The germline/somatic DNA damage repair gene mutations modulate the therapeutic response in Chinese patients with advanced pancreatic ductal adenocarcinoma. Shui L; Li X; Peng Y; Tian J; Li S; He D; Li A; Tian B; Li M; Gao H; An N; Yi C; Cao D J Transl Med; 2021 Jul; 19(1):301. PubMed ID: 34247626 [TBL] [Abstract][Full Text] [Related]
3. Targeting DNA damage repair pathways in pancreas cancer. Crowley F; Park W; O'Reilly EM Cancer Metastasis Rev; 2021 Sep; 40(3):891-908. PubMed ID: 34403012 [TBL] [Abstract][Full Text] [Related]
4. Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline BRCA Variants: Findings From 2 Phase 2 Nonrandomized Clinical Trials. Javle M; Shacham-Shmueli E; Xiao L; Varadhachary G; Halpern N; Fogelman D; Boursi B; Uruba S; Margalit O; Wolff RA; Golan T JAMA Oncol; 2021 May; 7(5):693-699. PubMed ID: 33662100 [TBL] [Abstract][Full Text] [Related]
6. Patient-Derived Xenograft Models of Pancreatic Cancer: Overview and Comparison with Other Types of Models. Garcia PL; Miller AL; Yoon KJ Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32456018 [TBL] [Abstract][Full Text] [Related]
7. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma. Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426 [TBL] [Abstract][Full Text] [Related]
8. Modeling human pancreatic ductal adenocarcinoma for translational research: current options, challenges, and prospective directions. Suri R; Zimmerman JW; Burkhart RA Ann Pancreat Cancer; 2020 Dec; 3():. PubMed ID: 33889840 [TBL] [Abstract][Full Text] [Related]
9. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis. Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164 [TBL] [Abstract][Full Text] [Related]
10. Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models. Heinrich MA; Mostafa AMRH; Morton JP; Hawinkels LJAC; Prakash J Adv Drug Deliv Rev; 2021 Jul; 174():265-293. PubMed ID: 33895214 [TBL] [Abstract][Full Text] [Related]
11. Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies. Restifo D; McDermott JR; Cvetkovic D; Dos Santos T; Ogier C; Surumbayeva A; Handorf EA; Schimke C; Ma C; Cai KQ; Olszanski AJ; Kathad U; Bhatia K; Sharma P; Kulkarni A; Astsaturov I Mol Cancer Ther; 2023 Oct; 22(10):1182-1190. PubMed ID: 37552607 [TBL] [Abstract][Full Text] [Related]
12. Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOX. Sehdev A; Gbolahan O; Hancock BA; Stanley M; Shahda S; Wan J; Wu HH; Radovich M; O'Neil BH Clin Cancer Res; 2018 Dec; 24(24):6204-6211. PubMed ID: 30131383 [TBL] [Abstract][Full Text] [Related]
13. Establishment of organoid models for pancreatic ductal adenocarcinoma and screening of individualized therapy strategy. Gong M; Meng H; Tan D; Li P; Qin J; An Q; Shi C; An J Animal Model Exp Med; 2023 Oct; 6(5):409-418. PubMed ID: 37890865 [TBL] [Abstract][Full Text] [Related]
14. The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids. Low RRJ; Lim WW; Nguyen PM; Lee B; Christie M; Burgess AW; Gibbs P; Grimmond SM; Hollande F; Putoczki TL Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638463 [TBL] [Abstract][Full Text] [Related]
16. DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives. Perkhofer L; Gout J; Roger E; Kude de Almeida F; Baptista Simões C; Wiesmüller L; Seufferlein T; Kleger A Gut; 2021 Mar; 70(3):606-617. PubMed ID: 32855305 [TBL] [Abstract][Full Text] [Related]